Fundraising Fox

A2 Biotherapeutics

2 known investors

a2bio.com ↗

A2 Bio develops precision CAR T-cell therapies using its Tmod cell engineering platform for both autologous and allogeneic applications. The company targets cancer and other serious diseases and advances its therapies through clinical trials.

BiotechDeep TechHealthtech

Investors · 2

The Column GroupSan Francisco · $30M
Samsara BioCapitalreportedPalo Alto

In the news

A2 Biotherapeutics: $80 Million (Series C) Raised For Advancing Clinical Development Of Precision Cell Therapiespulse2.com · Jan 2025A2 Biotherapeutics raises $80m to advance CAR-T therapies for solid tumours - Pharmaceutical Technologypharmaceutical-technology.com · Jan 2025A2 Biotherapeutics Closes $80 Million Series C Financing to Advance Clinical Development of Its Precision Cell Therapies Using Its Proprietary Tmod™ Technology Platformbusinesswire.com · Jan 2025A2 Biotherapeutics Raises $80M Series C Fundingfinsmes.com · Jan 2025Scoop: A2 Biotherapeutics raises $62M for solid tumor cell therapiesendpoints.news · Dec 2022A2 Biotherapeutics Closes $71.5M Series B Funding - FinSMEsfinsmes.com · Oct 2020

Frequently asked questions

What does A2 Biotherapeutics do?
A2 Bio develops precision CAR T-cell therapies using its Tmod cell engineering platform for both autologous and allogeneic applications. The company targets cancer and other serious diseases and advances its therapies through clinical trials.
Who are A2 Biotherapeutics's investors?
A2 Biotherapeutics's investors include The Column Group, Samsara BioCapital.